We are live on ! Find out more
Aviva

Aviva Portfolio holdings

AUM $59.6B
1-Year Est. Return 28.44%
This Fund
S&P 500
This Quarter Est. Return
+5.72%
1 Year Est. Return
+28.44%
3 Year Est. Return
+95.57%
5 Year Est. Return
+123.24%
10 Year Est. Return
+442.53%
AUM
$20.5B
AUM Growth
+$1.25B
Cap. Flow
+$361M
Cap. Flow %
1.76%
Top 10 Hldgs %
22.52%
Holding
1,000
New
89
Increased
345
Reduced
485
Closed
62

Top Buys

Rank Stock Value
1
FERG icon
Ferguson
FERG
+$309M
2
STLA icon
Stellantis
STLA
+$198M
3
MA icon
Mastercard
MA
+$54.7M
4
TFC icon
Truist Financial
TFC
+$47.4M
5
DIS icon
Walt Disney
DIS
+$41.8M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$55.7M
2
SWKS icon
Skyworks Solutions
SWKS
+$47.7M
3
RTX icon
RTX Corp
RTX
+$38.8M
4
ADBE icon
Adobe
ADBE
+$35.9M
5
ICE icon
Intercontinental Exchange
ICE
+$32.7M

Sector Composition

Rank Sector Weight
1 Technology 20.63%
2 Financials 14.68%
3 Consumer Discretionary 13.35%
4 Healthcare 12.77%
5 Communication Services 10.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAON icon
851
Aaon
AAON
$6.95B
$1.2M 0.01%
25,697
-7,452
-22% -$366K
PEGA icon
852
Pegasystems
PEGA
$5.09B
$1.2M 0.01%
20,972
+110
+0.5% +$7.19K
STAG icon
853
STAG Industrial
STAG
$7.5B
$1.2M 0.01%
35,664
-36,498
-51% -$1.16M
NVRO
854
DELISTED
NEVRO CORP.
NVRO
$1.2M 0.01%
8,598
-122
-1% -$19.9K
TPTX
855
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$1.2M 0.01%
12,658
-2,185
-15% -$260K
AZEK
856
DELISTED
The AZEK Co
AZEK
$1.2M 0.01%
+28,449
New +$1.22M
BCPC
857
Balchem Corp
BCPC
$5.26B
$1.2M 0.01%
9,526
-3,653
-28% -$444K
EGOV
858
DELISTED
NIC Inc
EGOV
$1.19M 0.01%
35,198
-26,906
-43% -$849K
HMSY
859
DELISTED
HMS Holdings Corp.
HMSY
$1.19M 0.01%
32,294
-19,881
-38% -$730K
BMI icon
860
Badger Meter
BMI
$3.87B
$1.19M 0.01%
12,803
-6,847
-35% -$689K
MSA icon
861
Mine Safety
MSA
$6.79B
$1.19M 0.01%
+7,946
New +$1.28M
JJSF icon
862
J&J Snack Foods
JJSF
$1.49B
$1.19M 0.01%
7,578
-2,448
-24% -$384K
ATR icon
863
AptarGroup
ATR
$8.69B
$1.19M 0.01%
8,389
-2,627
-24% -$362K
CRVL icon
864
CorVel
CRVL
$3.18B
$1.19M 0.01%
+34,743
New +$1.21M
CHE icon
865
Chemed
CHE
$7.16B
$1.19M 0.01%
2,581
-30
-1% -$14.7K
NEU icon
866
NewMarket
NEU
$7.24B
$1.19M 0.01%
3,123
-466
-13% -$186K
EGRX
867
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.19M 0.01%
28,435
-3,210
-10% -$149K
MLAB icon
868
Mesa Laboratories
MLAB
$551M
$1.18M 0.01%
4,861
-494
-9% -$136K
CWST icon
869
Casella Waste Systems
CWST
$5.76B
$1.18M 0.01%
+18,601
New +$1.12M
CCXI
870
DELISTED
ChemoCentryx, Inc.
CCXI
$1.18M 0.01%
23,023
-817
-3% -$49.2K
ATRI
871
DELISTED
Atrion Corp
ATRI
$1.18M 0.01%
1,838
-141
-7% -$93.5K
VRNS icon
872
Varonis Systems
VRNS
$4.67B
$1.18M 0.01%
22,947
-9,684
-30% -$574K
ICUI icon
873
ICU Medical
ICUI
$4.16B
$1.18M 0.01%
5,726
-925
-14% -$195K
STOK icon
874
Stoke Therapeutics
STOK
$1.84B
$1.18M 0.01%
30,266
-6,487
-18% -$369K
LOPE icon
875
Grand Canyon Education
LOPE
$4.22B
$1.17M 0.01%
10,962
-4,051
-27% -$402K

Similar funds

Aviva's Q1 2021 Portfolio in Review

As of Q1 2021, Aviva held 1,000 positions worth $20.5B, up 6.5% from $19.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Aviva's Q1 2021 filing shows 89 new, 345 increased, 485 reduced and 62 closed positions. Its largest new stake was Ferguson: 2,534,285 shares worth $302M. The largest sale was Apple, an estimated $55.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Aviva's largest Q1 2021 buy was Ferguson: 2,534,285 shares worth $302M.
  • Aviva added most to Stellantis in Q1 2021, an estimated $198M increase.
  • Aviva's biggest Q1 2021 reduction was Apple, cutting an estimated $55.7M.
  • Aviva fully exited Tiffany & Co. in Q1 2021, selling an estimated $7.08M.
  • Aviva's ten largest holdings make up 23% of its $20.5B portfolio in Q1 2021.
  • Aviva opened 89 new positions and closed 62 in Q1 2021.
  • Aviva's portfolio value rose 6.5% quarter-over-quarter to $20.5B.

Based on Aviva's 13F filing for Q1 2021, filed 13 May 2021.